Evidence map›Paper›PMID 34566513›Full record

ArticleOchsner journal2021

Stereotactic Body Radiotherapy in Contralateral Kidney Oligometastasis From Renal Cell Carcinoma in a Nephrectomized Patient.

Alessandro Di Marzo, Michelina Casale, Fabio Trippa, Paola Anselmo, Fabio Arcidiacono, Lorena Draghini, Sara Terenzi, Ernesto Maranzano

Registry-linked trialOpen access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Ochsner journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06416436 (Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06416436 phase1withdrawnnot on this mapstarted 2024, after this paper: background citation

Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes (ICARUS): A Phase I Dose-escalation Radiosurgery Study in Metastatic Cancers

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2024 to 2024Enrolled0ConditionsSolid TumorArmsAtezolizumab, Stereotactic Ablative Radiotherapy (SBRT)
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alessandro Di MarzoRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Michelina CasaleRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Fabio TrippaRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Paola AnselmoRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Fabio ArcidiaconoRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Lorena DraghiniRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Sara TerenziRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Ernesto MaranzanoRadiotherapy Oncology Centre, S. Maria Hospital, Terni, Italy.
Santa Maria Nuova Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic agentscarcinoma–renal celldrug therapyneoplasm metastasisradiosurgery

Identifiers

PMID34566513
PMCPMC8442205
OpenAlexW3156193397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.